Premarket Mover: Satsuma Pharmaceuticals Inc (STSA) Down 0.00%

Thursday, May 11, 2023 09:14 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Satsuma Pharmaceuticals Inc (STSA) Down 0.00%

Satsuma Pharmaceuticals Inc (STSA) is unmoved Thursday morning, with the stock flat 0.00% in pre-market trading to 1.06. STSA's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 93 out of 146 industries, Satsuma Pharmaceuticals Inc ranks higher than 38% of stocks. Satsuma Pharmaceuticals Inc has risen 47.22% over the past month, closing at $0.70 on April 13. During this period of time, the stock fell as low as $0.66 and as high as $1.47. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.

STSA has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Satsuma Pharmaceuticals Inc has a Long-Term Technical rank of 72. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 28% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, STSA ranks better than 83% of stocks.

Important Dates for Investors in STSA:

-Satsuma Pharmaceuticals Inc is set to release earnings on 8/7/2023. Over the last 12 months, the company has reported EPS of $-1.19. -We do not have a set dividend date for Satsuma Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Satsuma Pharmaceuticals Inc (STSA)